Price target
102.170.000.00%
The 23 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 30 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise
This is not investment advice and doesn't take into account your personal circumstances. It isn't a recommendation to buy, sell, or hold any asset. See the Terms of Use and always do your own research.
Frequently asked questions
The current price of EW is 91.60 USD — it has decreased by −1.04% in the past 24 hours. Watch Edwards Lifesciences Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Edwards Lifesciences Corporation stocks are traded under the ticker EW.
EW stock has risen by 2.42% compared to the previous week, the month change is a 2.67% rise, over the last year Edwards Lifesciences Corporation has showed a 18.15% increase.
We've gathered analysts' opinions on Edwards Lifesciences Corporation future price: according to them, EW price has a max estimate of 110.00 USD and a min estimate of 85.00 USD. Watch EW chart and read a more detailed Edwards Lifesciences Corporation stock forecast: see what analysts think of Edwards Lifesciences Corporation and suggest that you do with its stocks.
EW stock is 1.57% volatile and has beta coefficient of 0.58. Track Edwards Lifesciences Corporation stock price on the chart and check out the list of the most volatile stocks — is Edwards Lifesciences Corporation there?
Today Edwards Lifesciences Corporation has the market capitalization of 52.80 B, it has decreased by −0.82% over the last week.
Yes, you can track Edwards Lifesciences Corporation financials in yearly and quarterly reports right on TradingView.
Edwards Lifesciences Corporation is going to release the next earnings report on Oct 28, 2026. Keep track of upcoming events with our Earnings Calendar.
EW earnings for the last quarter are 0.78 USD per share, whereas the estimation was 0.74 USD resulting in a 4.97% surprise. The estimated earnings for the next quarter are 0.74 USD per share. See more details about Edwards Lifesciences Corporation earnings.
Edwards Lifesciences Corporation revenue for the last quarter amounts to 1.74 B USD, despite the estimated figure of 1.70 B USD. In the next quarter, revenue is expected to reach 1.68 B USD.
EW net income for the last quarter is 241.90 M USD, while the quarter before that showed 380.70 M USD of net income which accounts for 0.00% change. Track more Edwards Lifesciences Corporation financial stats to get the full picture.
No, EW doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Aug 16, 2026, the company has 16 K employees. See our rating of the largest employees — is Edwards Lifesciences Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Edwards Lifesciences Corporation EBITDA is 2.02 B USD, and current EBITDA margin is 29.45%. See more stats in Edwards Lifesciences Corporation financial statements.
Like other stocks, EW shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Edwards Lifesciences Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Edwards Lifesciences Corporation technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Edwards Lifesciences Corporation stock shows the strong buy signal. See more of Edwards Lifesciences Corporation technicals for a more comprehensive analysis.